Clinical Trial Update: Radiotherapy of Multiple Brain Metastases Using AGuIX® [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating radiotherapy for multiple brain metastases using the AGuIX nanoparticle radiosensitizer. The current trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• AGuIX

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Brain Metastases, Adult, Radiotherapy | Phase 2 | Status: UNKNOWN